Recommended Global Biotechnology Webinars & Conferences

Europe & UK

Euro Biotechnology 2027, France Euro Antibiotics 2027, France

Asia Pacific & Middle East

Canada

Biotechnology-2027, USA Bio America 2027, USA Biosimilars 2027, USA

Euro Biotechnology 2027

About Conference

The 30th European Biotechnology Congress, taking place on April 27–28, 2027, in Paris, France, will bring together leading researchers, scientists, academicians, industry professionals, healthcare experts, and policymakers to explore the latest advances in biotechnology. Under the theme "Advancing the Frontiers of Biotechnology through Research, Innovation, and Collaboration," the congress will provide an international platform for sharing groundbreaking research, innovative technologies, and practical applications across healthcare, agriculture, industrial biotechnology, and environmental sustainability.

The scientific program will feature keynote lectures, technical sessions, panel discussions, and poster presentations covering emerging areas such as synthetic biology, genetic engineering, genomics, bioinformatics, biopharmaceuticals, regenerative medicine, precision medicine, and sustainable bioprocessing. The congress aims to foster interdisciplinary collaboration, promote knowledge exchange, and strengthen partnerships between academia, industry, and regulatory organizations. By showcasing cutting-edge research and transformative technologies, the event seeks to accelerate innovation, address global challenges, and shape the future of biotechnology.

Sessions & Tracks

Track 1: AI-Driven Biotechnology and Digital Life Sciences

Explore the transformative role of artificial intelligence, machine learning, digital twins, and advanced analytics in biotechnology. Topics include AI-assisted drug discovery, laboratory automation, predictive biology, intelligent bioprocess optimization, and computational decision-making for next-generation biotechnology research. The session will showcase how AI is accelerating biological discoveries, reducing research timelines, and enhancing precision across the biotechnology value chain. Participants will gain insights into digital innovations that are reshaping laboratory research, clinical development, and industrial biotechnology.

Track 2: Genome Engineering and Functional Genomics

This session focuses on cutting-edge genome engineering technologies and functional genomics approaches for understanding gene function and disease biology. Discussions include large-scale genomic screening, functional annotation, comparative genomics, and emerging genome engineering platforms. Experts will present breakthroughs in genome-wide screening technologies and their applications in biomedical research and therapeutic development. The track will also explore ethical considerations and future opportunities in genome manipulation and precision biology.

Track 3: Multi-Omics and Systems Biotechnology

Advances in genomics, transcriptomics, proteomics, metabolomics, lipidomics, and integrative systems biology are transforming biotechnology research. This track explores how multi-omics data integration accelerates biomarker discovery, precision medicine, and biological network analysis. Sessions will highlight computational approaches that integrate complex biological datasets to improve disease understanding and therapeutic development. Participants will discover how systems biology is driving innovation across healthcare, agriculture, and industrial biotechnology.

Track 4: RNA Biology and Next-Generation RNA Therapeutics

RNA technologies have become one of the fastest-growing sectors in biotechnology. Topics include mRNA therapeutics, RNA editing, non-coding RNAs, circular RNA, RNA delivery platforms, and emerging RNA-based medicines beyond infectious diseases. Researchers will discuss novel RNA engineering strategies that are expanding treatment options for cancer, rare diseases, and neurological disorders. The session will also examine advances in RNA delivery systems and the future of RNA-based precision therapeutics.

Track 5: Cell and Gene Therapy Manufacturing

This session addresses innovations in cell therapy production, viral vectors, CAR-T manufacturing, gene delivery technologies, quality control, GMP manufacturing, regulatory challenges, and commercialization of advanced therapeutic medicinal products. Experts will discuss scalable manufacturing strategies that improve product consistency, safety, and regulatory compliance. The session will also highlight emerging technologies that support the commercialization of advanced cell and gene therapies worldwide.

Track 6: Advanced Biomanufacturing and Smart Bioprocess Engineering

Discover innovations in continuous bioprocessing, digital biomanufacturing, automation, process analytical technologies (PAT), Industry 4.0, robotics, and sustainable manufacturing systems for biologics and advanced therapeutics. Discussions will focus on improving manufacturing efficiency while reducing production costs and environmental impact. Participants will explore how digital transformation is creating smarter, more resilient, and highly efficient biomanufacturing facilities.

Track 7: Organoids, Organ-on-Chip and Advanced Disease Models

This rapidly expanding field provides alternatives to traditional animal models. Topics include patient-derived organoids, microphysiological systems, tissue chips, personalized disease modeling, toxicology testing, and precision drug development. The session will highlight innovative platforms that closely replicate human physiology for translational research and drug screening. Speakers will demonstrate how these technologies are improving predictive accuracy while supporting ethical biomedical research.

Track 8: Microbiome Engineering and Microbial Therapeutics

Explore how microbiome research is transforming medicine and biotechnology. Discussions include gut microbiome therapeutics, engineered probiotics, microbial ecology, live biotherapeutic products, microbiome diagnostics, and microbiome-based precision interventions. Recent discoveries linking microbial communities to human health, agriculture, and environmental sustainability will be explored. Participants will gain insights into microbiome engineering strategies that support disease prevention and therapeutic innovation.

Track 9: Protein Engineering and Computational Protein Design

Protein engineering has become central to therapeutic development and industrial biotechnology. This session focuses on enzyme engineering, antibody engineering, computational protein design, directed evolution, and AI-assisted protein structure prediction. Experts will present innovative computational tools that accelerate protein optimization for pharmaceutical and industrial applications. Discussions will also cover advances in enzyme discovery and next-generation biologic development.

Track 10: Biomarker Discovery and Precision Diagnostics

Novel biomarkers continue to drive personalized healthcare. This track covers liquid biopsy, molecular biomarkers, companion diagnostics, early disease detection, molecular pathology, digital diagnostics, and translational biomarker validation. Sessions will examine emerging diagnostic technologies that improve clinical decision-making and patient stratification. Participants will explore how biomarker research supports earlier intervention and more effective personalized therapies.

Track 11: Immunoengineering and Advanced Therapeutics

This session highlights biotechnology innovations that modulate the immune system. Topics include immune cell engineering, therapeutic antibodies, cytokine engineering, cancer immunotherapy, autoimmune therapeutics, and next-generation biologics. Discussions will showcase cutting-edge immunotherapies that are transforming the treatment of cancer and immune-mediated diseases. The track will also explore novel engineering approaches that improve therapeutic efficacy and long-term clinical outcomes.

Track 12: Biotechnology for Rare and Genetic Diseases

Rare diseases represent one of the fastest-growing biotechnology sectors. Discussions include orphan drug development, precision therapeutics, genomic diagnostics, newborn screening, personalized treatment strategies, and regulatory incentives. Experts will discuss innovative therapeutic platforms designed to address unmet clinical needs in rare genetic disorders. The session will also highlight collaborative initiatives that accelerate research, diagnosis, and patient access to advanced therapies.

Track 13: Biosensors, Wearable Biotechnology and Digital Health

This session focuses on next-generation biosensing technologies for healthcare and biotechnology. Topics include wearable biosensors, implantable devices, smart diagnostics, remote monitoring, bioelectronics, and integrated digital healthcare systems. Participants will discover how real-time monitoring technologies are improving disease management, preventive healthcare, and patient engagement. Discussions will also examine the integration of biosensors with AI and connected digital health platforms.

Track 14: Sustainable Biotechnology and Circular Bioeconomy

Biotechnology plays an essential role in achieving global sustainability goals. Discussions include carbon-negative biotechnology, bio-based materials, sustainable chemicals, industrial decarbonization, waste valorization, and circular bioeconomy innovations. The session will present innovative solutions that support environmentally responsible manufacturing and efficient resource utilization. Experts will also discuss policy initiatives and industrial strategies driving the transition toward a sustainable bioeconomy.

Track 15: Synthetic Cells and Cell-Free Biotechnology

Synthetic biological systems and cell-free platforms are opening entirely new avenues for biotechnology. This track explores artificial cells, synthetic biomolecular systems, cell-free protein production, rapid diagnostics, and programmable biological circuits. Researchers will present emerging technologies that enable faster prototyping, flexible manufacturing, and portable diagnostic solutions. The session will also highlight future applications of synthetic biological systems across medicine, industry, and environmental biotechnology.

Track 16: Translational Biotechnology and Clinical Innovation

Bridging laboratory discoveries to clinical application remains a major priority. Topics include translational medicine, first-in-human studies, biotechnology commercialization, regulatory science, technology transfer, and successful bench-to-bedside strategies. The session will showcase collaborative models that accelerate the movement of scientific discoveries into clinical practice. Participants will explore successful case studies demonstrating effective translation of biotechnology innovations into healthcare solutions.

Track 17: Biotechnology Entrepreneurship, Venture Capital and Innovation

Designed for industry professionals and startup founders, this session explores biotech entrepreneurship, venture financing, technology commercialization, intellectual property, startup ecosystems, corporate partnerships, and investment opportunities. Discussions will provide valuable insights into building successful biotechnology ventures and attracting strategic investment. Experts will share experiences on innovation management, market entry, and sustainable growth within the global biotechnology sector.

Track 18: Regulatory Science, Quality Systems and Global Compliance

Regulatory science has become increasingly important in biotechnology innovation. Discussions include FDA, EMA and MHRA regulations, GMP, GLP, GCP, quality by design (QbD), regulatory strategy, risk management, and global product approvals. The session will examine evolving international regulatory frameworks that facilitate safe and efficient product development. Participants will gain practical knowledge on maintaining quality standards throughout the biotechnology product lifecycle.

Track 19: Emerging Technologies in Biotechnology

Explore disruptive technologies reshaping biotechnology, including quantum biotechnology, autonomous laboratories, digital biology, programmable biomaterials, advanced biofabrication, and next-generation research platforms that will define the future of life sciences. Experts will discuss breakthrough innovations expected to transform biomedical research, industrial biotechnology, and healthcare over the coming decade. The session will provide valuable perspectives on future scientific trends and emerging investment opportunities.

Track 20: Global Biotechnology Collaboration and Future Innovation

This concluding track examines international research collaborations, public-private partnerships, Horizon Europe initiatives, biotechnology policy, global funding opportunities, and strategies for accelerating scientific innovation through multidisciplinary collaboration. The session will emphasize the importance of cross-border partnerships in addressing complex global health, environmental, and industrial challenges. Participants will explore international funding mechanisms, collaborative research networks, and strategies for advancing biotechnology through global scientific cooperation.

Market Analysis

Biotechnology Market Analysis

The global biotechnology market is experiencing robust growth, driven by rapid advances in artificial intelligence, genomics, synthetic biology, cell and gene therapies, and precision medicine. Increasing investments in biotechnology research, growing demand for biologics, expanding applications across healthcare, agriculture, industrial biotechnology, and environmental sustainability, along with supportive government initiatives, continue to accelerate market growth worldwide.

A glimpse of the major drivers and restraints affecting the biotechnology market is mentioned below:

Drivers

Increasing investments in biotechnology research and innovation
Rising adoption of AI and digital technologies in life sciences
Growing demand for biologics, cell & gene therapies, and precision medicine
Expansion of sustainable biomanufacturing and bioeconomy initiatives
Strong collaborations between academia, industry, and healthcare organizations

Restraints

High research and manufacturing costs
Complex regulatory approval processes
Ethical and biosafety concerns
Commercialization and scalability challenges
Shortage of skilled biotechnology professionals

The biotechnology market continues to evolve through technological innovation, strategic collaborations, and increasing investment in life sciences. Market analysis covers key technology segments including AI & Digital Biotechnology, Genome Engineering & Functional Genomics, Synthetic Biology, Multi-Omics Technologies, RNA Therapeutics, Cell & Gene Therapy, Advanced Biomanufacturing, and Computational Biology. Major application areas include Drug Discovery & Development, Precision Medicine, Molecular Diagnostics, Regenerative Medicine, Industrial Biotechnology, Agricultural Biotechnology, and Environmental Biotechnology, serving biotechnology companies, pharmaceutical and biopharmaceutical organizations, CROs, academic institutions, hospitals, and government research organizations.

Geographically, the biotechnology market spans North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, with North America and Europe leading global innovation and commercialization. The competitive landscape features leading biotechnology and life science companies including Roche, Novartis, AstraZeneca, GSK, Pfizer, Sanofi, BioNTech, Moderna, Amgen, Genentech, Illumina, Thermo Fisher Scientific, Merck KGaA, Sartorius AG, Lonza Group, and Agilent Technologies, which continue to drive innovation through strategic partnerships, acquisitions, product development, and research investments.

METHODOLOGY:

A combination of primary and secondary research has been used to determine market estimates and forecasts. Secondary research sources include company reports, scientific journals, regulatory publications, industry databases, and technical literature, while primary research consists of interviews with biotechnology experts, researchers, and industry professionals to validate market trends and future opportunities.

SEGMENTATIONS IN REPORT: